BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25409474)

  • 1. Clinical infectious diseases pharmacists in the United States: a problem of both supply and demand.
    Gauthier TP; Worley M; Laboy V; Hernandez L; Unger NR; Sherman EM; Frederick C; Aragon L
    Clin Infect Dis; 2015 Mar; 60(5):826-7. PubMed ID: 25409474
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
    Drew RH; White R; MacDougall C; Hermsen ED; Owens RC;
    Pharmacotherapy; 2009 May; 29(5):593-607. PubMed ID: 19397466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging Pharmacy Students, Residents, and Fellows in Antimicrobial Stewardship.
    Chahine EB; El-Lababidi RM; Sourial M
    J Pharm Pract; 2015 Dec; 28(6):585-91. PubMed ID: 24399574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Infectious Diseases Pharmacists (SIDP) position papers.
    Strayer AH
    Pharm Pract Manag Q; 1996 Jul; 16(2):62-5. PubMed ID: 10161614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting more conservative prescribing.
    Schiff GD; Galanter WL
    JAMA; 2009 Feb; 301(8):865-7. PubMed ID: 19244196
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstrating the true value of antimicrobial stewardship programs.
    Chapman B; Gonzalez L
    Am J Health Syst Pharm; 2015 Aug; 72(15):1263-4. PubMed ID: 26195648
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimizing antimicrobial resistance: the key role of the infectious diseases physician.
    McGowan JE
    Clin Infect Dis; 2004 Apr; 38(7):939-42. PubMed ID: 15034824
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial commentary: improving prescribers to advance antimicrobial stewardship.
    Wenzler E; Rodvold KA; Danziger LH
    Clin Infect Dis; 2015 Apr; 60(8):1259-61. PubMed ID: 25595751
    [No Abstract]   [Full Text] [Related]  

  • 9. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy.
    Carmichael JM; O'Connell MB; Devine B; Kelly HW; Ereshefsky L; Linn WD; Stimmel GL
    Pharmacotherapy; 1997; 17(5):1050-61. PubMed ID: 9324201
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Knox K, Lawson W, Dean B, Holmes A. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist-a UK perspective. J Hosp Infect 2003; 53: 85-90.
    Wyllie S; Weeks C; Khachi H; Vickers M; Jones G
    J Hosp Infect; 2003 Jul; 54(3):246. PubMed ID: 12855244
    [No Abstract]   [Full Text] [Related]  

  • 11. The infectious diseases physician in the future of healthcare: not only about antibiotic prescribing.
    Nahass RG
    Clin Infect Dis; 2015 Mar; 60(5):773-6. PubMed ID: 25416751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflections on prescribing pharmacists. A clinical blueprint.
    Perchak GJ
    Am Pharm; 1983 Feb; NS23(2):8-9. PubMed ID: 6829422
    [No Abstract]   [Full Text] [Related]  

  • 13. Is medication review by pharmacists of any use?
    Zermansky AG; Freemantle N
    Pharmacoeconomics; 2007; 25(2):91-2. PubMed ID: 17249852
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an expert professional curriculum for antimicrobial pharmacists in the UK.
    Sneddon J; Gilchrist M; Wickens H
    J Antimicrob Chemother; 2015 May; 70(5):1277-80. PubMed ID: 25564563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting infection: an ongoing challenge, part 1.
    Turkoski BB
    Orthop Nurs; 2005; 24(1):40-6; quiz 47-8. PubMed ID: 15722973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forward: combating resistance: infectious diseases.
    Gold B
    Future Med Chem; 2013 Jul; 5(11):1175-6. PubMed ID: 23859196
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant Publications on Infectious Diseases Pharmacotherapy in 2017.
    Skoglund EW; Dotson KM; Dempsey CJ; Su CP; Foolad F; Janak C; Sofjan AK; Phe K
    J Pharm Pract; 2019 Oct; 32(5):534-545. PubMed ID: 30099951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could repurposing existing drugs be an efficient protective method against microbial biologic threats?
    Chopra S
    Future Microbiol; 2013 Aug; 8(8):951-2. PubMed ID: 23902140
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the infectious diseases physician in setting guidelines for antimicrobial use.
    Bryan CS
    Bull N Y Acad Med; 1987; 63(6):627-37. PubMed ID: 3479215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination with immunoglobulin and antibiotics for the treatment of infectious diseases].
    Sasada M
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():261-5. PubMed ID: 12717981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.